Yaniv Zager to Combined Modality Therapy
This is a "connection" page, showing publications Yaniv Zager has written about Combined Modality Therapy.
Connection Strength
0.284
-
Zager Y, Hoffman A, Dreznik Y, Jacoby H, Cordoba M, Horesh N, Nevler A, Gutman M, Berger Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surg Oncol. 2020 Dec; 35:321-327.
Score: 0.161
-
Ram E, Zager Y, Carter D, Anteby R, Haik J, Nachmany I, Horesh N. Efficacy and safety of RD2 Ver.02, a whole blood clot therapy, coupled with a minimally invasive procedure in pilonidal sinus: a phase II study. Tech Coloproctol. 2024 08 13; 28(1):97.
Score: 0.053
-
Berger Y, Jacoby H, Zager Y, Lebedyev A, Gutman M, Hoffman A. [CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS OF COLORECTAL ORIGIN - FIRST 100 CASES]. Harefuah. 2019 Apr; 158(4):227-232.
Score: 0.036
-
Jacoby H, Berger Y, Barda L, Sharif N, Zager Y, Lebedyev A, Gutman M, Hoffman A. Implications of Stoma Formation as Part of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Surg. 2018 07; 42(7):2036-2042.
Score: 0.034